060sek
0,7 %
Date:2024-07-24Time:17:29:00Latest report:Q1-2024List:First NorthTicker:TOL
Market Cap:118 msekEnterprise Value:108 msekNet Sales:- msekEarnings:-6,30 msekEmployees:0ISIN:SE0007438577

Ratios

10-year key figure history for Toleranzia turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Toleranzia with index and moving average MA50 and MA200.

Stockprice:0,60
MA50:0,63
MA200:0,52
Price/MA200:15,1 %
RSI (14):47,5
Price/MA50:-4,8 %

Description

Toleranzia AB is a Swedish biotechnology Company. The company develops drugs that harness the power of the immune system to treat autoimmune orphan diseases The company's drug candidate, TOL2, is being developed for the treatment of the autoimmune neuromuscular disease myasthenia gravis, an orphan disease.

Medical Equipment